Biologicals in gastroenterology: TNF-blockers

被引：1

作者：

Scharl, M. ^{[1
]}

Rogler, G. ^{[1
]}

机构：

[1] Univ Spital Zurich, Dept Innere Med, Klin Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2010年 / 135卷 / 45期

关键词：

inflammatory bowel disease; Crohn's disease; ulcerative colitis; TNF-blocker; biologicals; CROHNS-DISEASE; INFLIXIMAB MAINTENANCE; EPISODIC TREATMENT; ADALIMUMAB; THERAPY; EFFICACY; SAFETY; INFECTIONS; ANTIBODY;

D O I：

10.1055/s-0030-1267508

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TNF-blockers represent a well accepted therapeutic option in the treatment of inflammatory bowel disease. Though they are successfully used in many patients, they can also exert severe side effects, such as infectious diseases. Therefore, a careful review of the patient history as well as a continuous evaluation of the patients state of health is crucial before starting an anti-TNF therapy during the therapeutic treatment. In addition, we review also the possibilities by loss of efficacy of an anti-TNF therapy, such as dose increase or re-induction therapy. © 2010 Georg Thieme Verlag KG Stuttgart · New York.

引用

下载

页码：2243 / 2252

页数：10

共 50 条

[1] Topical application of TNF-blockers
Teich, N.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (08) : 381 - 385
[2] Tuberculosis under Treatment with TNF-Blockers
不详
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (01): : 4 - 4
[3] SWITCHING TNF-BLOCKERS: WHAT IS THE EVIDENCE
Lie, E.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 31 - 31
[4] Do TNF-blockers reduce or induce uveitis
Cobo-Ibanez, T.
Ordonez, M. del Carmen
Munoz-Fernandez, S.
Madero-Prado, R.
Martin-Mola, E.
RHEUMATOLOGY, 2008, 47 (05) : 731 - 732
[5] Leflunomide in combination with TNF-blockers for Methotrexate intolerance
Krueger, K.
Mangerund, B.
ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (02): : 165 - +
[6] Lonc-term safety of TNF-blockers
Van Vollenhoven, R.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 720 - 720
[7] Financial basis for the prescription of TNF-blockers in Germany
Braun, J.
Dybowski, F.
Fendler, C.
Bergerhausen, H. J.
Sieper, J.
AKTUELLE RHEUMATOLOGIE, 2006, 31 (06) : 322 - 328
[8] ARE TNF-BLOCKERS TRUE DMARDS IN AS - HOW STRONG IS THE EVIDENCE?
Gensler, L. S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 769 - 770
[9] Survival of treatment with TNF-blockers on patients with rheumatoid arthritis and with spondylarthropaties
Abreu Trigueros, P.
Rubio Garcia, J.
Illera Martin, O.
Morell Hita, J.
Ruiz Bonilla, G.
Zea Mendoza, A.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 173 - 173
[10] No increase of severe infections in RA patients treated with TNF-blockers
Jacobsson, LTH
Turesson, C
Gülfe, A
Kapetanovic, MC
Petersson, IF
Saxne, T
Geborek, P
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S341 - S341

← 1 2 3 4 5 →